Bioidentical Hormones
Topic OverviewBioidentical hormones are made in
a laboratory. They are based on compounds found in plants (usually soybeans or
wild yams). After the plant-based hormone is
processed, its structure is said to be identical to the
estrogen,
progesterone, or
androgen hormone your body makes. (Well-designed
studies have yet to prove this theory.footnote 1) A compounding
pharmacist can offer you a custom-made formulation in one of many forms. You might get a capsule, a skin cream or gel, a tablet to dissolve under your tongue,
a suppository, or a nose spray. Some commonly prescribed estrogens and
progesterones are bioidenticals, such as Estrace (estradiol). There's a major difference between custom-made formulations and commercial products. Commercial products are
regulated and tested for purity and potency, but compounding pharmacies are not. Just like synthetic hormone therapy, bioidentical hormones
are prescribed to increase or stabilize a woman's hormone levels.
This is most often done during perimenopause, when hormone levels change
unpredictably. It's also done after menopause, when the hormones drop to low levels.
The most important fact to remember about taking bioidentical hormones is that the risks are not yet well understood. They may have the same breast cancer, stroke, blood clot, heart disease, and dementia risks that synthetic hormone therapy has.footnote 1 ReferencesCitations- North American Menopause Society (2012). The 2012 hormone therapy position statement
of the North American Menopause Society. Menopause, 19(3): 257-271. DOI:
10.1097/gme.0b013e31824b970a. Accessed April 18, 2016.
CreditsByHealthwise Staff Primary Medical ReviewerAnne C. Poinier, MD - Internal Medicine Martin J. Gabica, MD - Family Medicine Kathleen Romito, MD - Family Medicine Specialist Medical ReviewerCarla J. Herman, MD, MPH - Geriatric Medicine Current as ofOctober 13, 2016 Current as of:
October 13, 2016 North American Menopause Society (2012). The 2012 hormone therapy position statement
of the North American Menopause Society. Menopause, 19(3): 257-271. DOI:
10.1097/gme.0b013e31824b970a. Accessed April 18, 2016. Last modified on: 8 September 2017
|
|
|
|
|
|